Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
COL11A1 (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
COL11A1 May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils. Defects in COL11A1 are the cause of Stickler syndrome type 2 (STL2); also known as Stickler syndrome vitreous type 2. STL2 is an autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. Defects in COL11A1 are the cause of Marshall syndrome (MRSHS). It is an autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. Defects in COL11A1 are the cause of fibrochondrogenesis type 1 (FBCG1). A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. Belongs to the fibrillar collagen family. 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Secreted; Extracellular matrix; Secreted, signal peptide
Cellular Component: collagen type XI; endoplasmic reticulum lumen; extracellular region
Molecular Function: protein binding, bridging; extracellular matrix binding; metal ion binding; extracellular matrix structural constituent
Biological Process: extracellular matrix disassembly; proteoglycan metabolic process; collagen catabolic process; inner ear morphogenesis; extracellular matrix organization and biogenesis; collagen fibril organization; sensory perception of sound; visual perception; ventricular cardiac muscle morphogenesis; chondrocyte development; detection of mechanical stimulus involved in sensory perception of sound; cartilage condensation; embryonic skeletal morphogenesis
Reference #:  P12107 (UniProtKB)
Alt. Names/Synonyms: CO11A1; COBA1; COL11A1; COLL6; Collagen alpha-1(XI) chain; collagen XI, alpha-1 polypeptide; collagen, type XI, alpha 1; STL2
Gene Symbols: COL11A1
Molecular weight: 181,065 Da
Basal Isoelectric point: 5.06  Predict pI for various phosphorylation states
Select Structure to View Below

COL11A1

Protein Structure Not Found.


STRING  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  DISEASE  |  Scansite  |  Pfam  |  Phospho.ELM  |  NetworKIN  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene  |  Ensembl Protein


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

► Hide Isoforms
 
0 1 T57-p SPEGISKttGFCtNR
0 1 T58-p PEGISKttGFCtNRK
0 1 T62-p SKttGFCtNRKNsKG
0 2 S67-p FCtNRKNsKGsDtAy
0 1 S70-p NRKNsKGsDtAyRVS
0 2 T72-p KNsKGsDtAyRVSKQ
0 2 Y74-p sKGsDtAyRVSKQAQ
0 1 S193-p TTKPLDRsERAIVDT
0 1 - gap
0 1 - gap
0 1 - gap
0 1 S355-p YDSQRKNsEDTLYEN
0 1 Y386-p GEYDFYEyKEYEDKP
0 2 K875-ac GARGVAGkPGPRGQR
0 1 K1281 PKGERGEKGEAGPPG
0 1 K1296 AAGPPGAKGPPGDDG
0 1 S1682-p FKRGKLLsYLDVEGN
0 1 Y1721-p CHQSAAWyDVSSGSY
0 2 T1766-p SRKGYEKtVIEINtP
0 2 T1772-p KtVIEINtPKIDQVP
  COL11A1 iso2  
T57 SPEGISKTTGFCTNR
T58 PEGISKTTGFCTNRK
T62 SKTTGFCTNRKNSKG
S67 FCTNRKNSKGSDTAY
S70 NRKNSKGSDTAYRVS
T72 KNSKGSDTAYRVSKQ
Y74 SKGSDTAYRVSKQAQ
S193 TTKPLDRSERAIVDT
K269-ub KKSNFKKkMRTVATk
K276-ub kMRTVATkSkEKSKK
K278-ub RTVATkSkEKSKKFT
S367 YDSQRKNSEDTLYEN
Y398 GEYDFYEYKEYEDKP
K887-ac GARGVAGkPGPRGQR
K1293 PKGERGEKGEAGPPG
K1308 AAGPPGAKGPPGDDG
S1694 FKRGKLLSYLDVEGN
Y1733 CHQSAAWYDVSSGSY
T1778 SRKGYEKTVIEINTP
T1784 KTVIEINTPKIDQVP
  mouse

 
T56 SPVGISKTTGFCTNR
T57 PVGISKTTGFCTNRK
T61 SKTTGFCTNRKNSKD
S66 FCTNRKNSKDPDVAY
P69 NRKNSKDPDVAYRVT
V71 KNSKDPDVAYRVTEE
Y73 SKDPDVAYRVTEEAQ
S192 ITKPLDRSERSIVDT
- gap
- gap
- gap
S353 YDVQRNTSEDILYGN
Y384 GEYDFYEYKEYEERT
K873 GARGIAGKPGPRGQR
K1279 LKGERGEKGEAGPPG
K1294 AAGPAGIKGPPGDDG
S1680 FKRGKLLSYLDVEGN
Y1719 CHQSAAWYDVLSGSY
T1764 SRKGYEKTVIEINTP
T1770 KTVIEINTPKIDQVP
  rat

 
T56 SPVGISKTTGFCTSR
T57 PVGISKTTGFCTSRK
T61 SKTTGFCTSRKNSKD
S66 FCTSRKNSKDPDIAY
P69 SRKNSKDPDIAYRVT
I71 KNSKDPDIAYRVTEE
Y73 SKDPDIAYRVTEEAQ
S192 ITKPLDRSERSIVDT
- gap
- gap
- gap
S314 YDVQRNISEDILYGN
Y345 GEYDFYEYKEYEERT
K834 GARGIAGKPGPRGQR
K1240-ub PKGERGEkGEAGPPG
K1255-ub AAGPPGIkGPPGDDG
S1641 FKRGKLLSYLDVEGN
Y1680 CHQSTAWYDVLSGSY
T1725 SRKGYEKTVIEINTP
T1731 KTVIEINTPKIDQVP
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.